Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velphoro vs Calcium Acetate in Paediatric and Adolescent CKD Patients with Hyperphosphataemia
2015-004155-43Phase 3Terminated
- Sponsor
- Vifor Fresenius Medical Care Renal Pharma
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of iron sucrose in hyperphosphatemia and chronic kidney disease (CKD) (2 arms), sponsored by Vifor Fresenius Medical Care Renal Pharma. Started Feb 2016; status: terminated.
02
Drugs
iron sucrose
03
Conditions
hyperphosphatemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on 2015-004155-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004155-43.